Research graph
References from Etanercept-Induced Cutaneous Necrotizing Vasculitis in a Patient With Rheumatoid Arthritis: A Case Report and Literature Review. Local targets link to admitted publications; unresolved targets remain external evidence.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
10.1136/ard-2022-223356 · 2023 · External reference
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
10.1097/md.0b013e3181441a68 · 2007 · External reference
Vasculitis associated with tumor necrosis factor-α inhibitors
10.1016/j.mayocp.2012.04.011 · 2012 · External reference
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
10.1002/art.1780380107 · 1995 · External reference
Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France
10.1016/j.jbspin.2006.02.010 · 2006 · External reference
Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents
2004 · External reference
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database
10.1080/00325481.2026.2696097 · 2026 · External reference
A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis
10.1007/s40257-014-0076-6 · 2014 · External reference
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
10.1111/jdv.70249 · 2026 · External reference
Leukocytoclastic vasculitis due to etanercept
2000 · External reference
Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis
10.5414/cnp62234 · 2004 · External reference
Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis
10.1093/ndt/gfh832 · 2005 · External reference
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.37715 · 2013 · External reference
Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.40375 · 2018 · External reference
Drug-induced cutaneous vasculitides
2015 · External reference
Vasculitis associated with rheumatoid arthritis: a case-control study
10.1093/rheumatology/ket475 · 2014 · External reference
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study
10.3109/03009742.2014.923931 · 2015 · External reference
Cryoglobulinemic vasculitis in primary Sjögren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease
10.1016/j.semarthrit.2020.07.013 · 2020 · External reference
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients
10.1007/s10875-008-9214-3 · 2008 · External reference
Management of cutaneous vasculitis
10.1016/j.lpm.2020.104033 · 2020 · External reference
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
10.1002/art.1780380107 · ExternalCitation · doi-reference
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.37715 · ExternalCitation · doi-reference
Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.40375 · ExternalCitation · doi-reference
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients
10.1007/s10875-008-9214-3 · ExternalCitation · doi-reference
A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis
10.1007/s40257-014-0076-6 · ExternalCitation · doi-reference
Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France
10.1016/j.jbspin.2006.02.010 · ExternalCitation · doi-reference
Management of cutaneous vasculitis
10.1016/j.lpm.2020.104033 · ExternalCitation · doi-reference
Vasculitis associated with tumor necrosis factor-α inhibitors
10.1016/j.mayocp.2012.04.011 · ExternalCitation · doi-reference
Cryoglobulinemic vasculitis in primary Sjögren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease
10.1016/j.semarthrit.2020.07.013 · ExternalCitation · doi-reference
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database
10.1080/00325481.2026.2696097 · ExternalCitation · doi-reference
Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis
10.1093/ndt/gfh832 · ExternalCitation · doi-reference
Vasculitis associated with rheumatoid arthritis: a case-control study
10.1093/rheumatology/ket475 · ExternalCitation · doi-reference
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
10.1097/md.0b013e3181441a68 · ExternalCitation · doi-reference
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
10.1111/jdv.70249 · ExternalCitation · doi-reference
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
10.1136/ard-2022-223356 · ExternalCitation · doi-reference
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study
10.3109/03009742.2014.923931 · ExternalCitation · doi-reference
Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis
10.5414/cnp62234 · ExternalCitation · doi-reference
